✦ 24h Briefing Top Stories World U.S.India Business Technology Science Health Sports Entertainment

Loading

Fetching the latest headlines…

NabkaNews aggregates headlines from thousands of publishers worldwide via Google News, and provides AI-generated summaries and briefings for convenience. Every story links to its original source. We do not host or claim ownership of third-party reporting, and AI summaries may contain errors — always verify with the original source.

24h Briefing Top Stories World U.S.India Business Technology Science Health Sports Entertainment

Disclaimer Privacy Policy Terms of Use

© 2026 NabkaNews · World · U.S. · India — updated continuously. NabkaNews is an independent news aggregator and is not affiliated with any publisher shown.

Wegovy SC approved in Japan for MASH · NabkaNews

← Back to headlines

Wegovy SC approved in Japan for MASH

The Pharma Letter·Jun 22

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

Wegovy has been approved in Japan for the treatment of MASH. Additionally, approvals for Wegovy to treat a form of liver disease have been granted in the UK and the US. The specific details of these approvals, such as the conditions treated, vary across reports.

Full coverage

Wegovy wins UK approval to treat form of liver disease

The Pharma Letter·Jul 3

FDA Approves Wegovy to Treat Serious Liver Disease

Renal and Urology News·Aug 25

Novo Nordisk's Wegovy gets accelerated US approval for liver disease MASH

Reuters·Aug 15

FDA accepts NDA for Roche’s giredestrant in ESR1-mutated, ER-positive advanced breast cancer

The Pharma Letter·Feb 20

Novo Nordisk breach draws ransom claims from hacker groups

The Pharma Letter·Jun 24

Sanofi shares jump as Dupixent does it again

The Pharma Letter·Jul 25

View original report at The Pharma Letter ↗